中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2015年
15期
96-97
,共2页
黄世香%黄杰%莫与海%黎祥伟%姚富黎%岑定善%刘远林%贝光明%植华
黃世香%黃傑%莫與海%黎祥偉%姚富黎%岑定善%劉遠林%貝光明%植華
황세향%황걸%막여해%려상위%요부려%잠정선%류원림%패광명%식화
疏血通注射液%COPD%肺动脉高压
疏血通註射液%COPD%肺動脈高壓
소혈통주사액%COPD%폐동맥고압
Shuxuetong injection%COPD%Pulmonary hypertension
目的：研究疏血通注射液对COPD患者急性加重期肺动脉高压影响的临床效果。方法：选取我院2012年9月—2014年10月收治的64例COPD急性加重期肺动脉高压患者的临床资料，根据数字随机分组法原则，将患者分为两组，每组各32例患者，对照组采用常规治疗，观察组在常规治疗基础上给予疏血通注射液治疗，比较两组患者的肺动脉平均压、内皮素、血栓素B2的变化情况及其治疗效果。结果：①治疗后，观察组的平均肺动脉压、内皮素、血栓素B2指标改善效果优于对照组，对比有统计学意义（P＜0.05）。②观察组中，6例患者治疗有效，总有效率为96.9%。对照组，总有效率为81.3%。观察组治疗有效率优于对照组，对比有统计学意义（P＜0.05）。结论：疏血通注射液的应用可以使PAH降低，对血小板功能可起到调节作用，是一种可靠的治疗方式，值得临床推广应用。
目的：研究疏血通註射液對COPD患者急性加重期肺動脈高壓影響的臨床效果。方法：選取我院2012年9月—2014年10月收治的64例COPD急性加重期肺動脈高壓患者的臨床資料，根據數字隨機分組法原則，將患者分為兩組，每組各32例患者，對照組採用常規治療，觀察組在常規治療基礎上給予疏血通註射液治療，比較兩組患者的肺動脈平均壓、內皮素、血栓素B2的變化情況及其治療效果。結果：①治療後，觀察組的平均肺動脈壓、內皮素、血栓素B2指標改善效果優于對照組，對比有統計學意義（P＜0.05）。②觀察組中，6例患者治療有效，總有效率為96.9%。對照組，總有效率為81.3%。觀察組治療有效率優于對照組，對比有統計學意義（P＜0.05）。結論：疏血通註射液的應用可以使PAH降低，對血小闆功能可起到調節作用，是一種可靠的治療方式，值得臨床推廣應用。
목적：연구소혈통주사액대COPD환자급성가중기폐동맥고압영향적림상효과。방법：선취아원2012년9월—2014년10월수치적64례COPD급성가중기폐동맥고압환자적림상자료，근거수자수궤분조법원칙，장환자분위량조，매조각32례환자，대조조채용상규치료，관찰조재상규치료기출상급여소혈통주사액치료，비교량조환자적폐동맥평균압、내피소、혈전소B2적변화정황급기치료효과。결과：①치료후，관찰조적평균폐동맥압、내피소、혈전소B2지표개선효과우우대조조，대비유통계학의의（P＜0.05）。②관찰조중，6례환자치료유효，총유효솔위96.9%。대조조，총유효솔위81.3%。관찰조치료유효솔우우대조조，대비유통계학의의（P＜0.05）。결론：소혈통주사액적응용가이사PAH강저，대혈소판공능가기도조절작용，시일충가고적치료방식，치득림상추엄응용。
Objective:To study the clinical effect of Shuxuetong injection on pulmonary hypertension of patients with COPD in acute and aggravating stage.Methods:64 patients with pulmonary hypertension caused by COPD in acute and aggravating stage in our hospital from September 2012 to October 2014 were divided into two groups according to figures randomized law principles,32 patients in each group.The control group was given conventional treatment and the observation group received conventional treatment and Shuxuetong injection. The changes of mean pulmonary arterial pressure, endothelin,and thromboxane B2 of the two groups were compared.Results:①After treatment,the improvement of mean pulmonary arterial pressure and endothelin, thromboxane B2 index of the observation group was better than that of the control group and the difference was statistically significant(P<0.05).②25 patients of theobservation groupwere cured, 6 had effect,the total effective rate was 96.9%.10 cases of the control group were cured,16 cases had effect,the total effective rate was 81.3%.The effective rate of the observation group was higher than that of the control group and the differencr was statistically significant (P<0.05).Conclusion:The applications of Shuxuetong injection can reduce PAH and regulat platelet function.It is a reliable treatment and worthy of clinical application.
